Found: 40
Select item for more details and to access through your institution.
Physicians, paraproteins and progress: diagnosis and management of myeloma.
- Published in:
- British Journal of Hospital Medicine (17508460), 2019, v. 80, n. 2, p. 91, doi. 10.12968/hmed.2019.80.2.91
- By:
- Publication type:
- Article
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
- Published in:
- Nature Medicine, 2002, v. 8, n. 4, p. 410, doi. 10.1038/nm0402-410
- By:
- Publication type:
- Article
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26551-x
- By:
- Publication type:
- Article
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open‐label, randomised, phase III trial.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 267, doi. 10.1111/bjh.18600
- By:
- Publication type:
- Article
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 5, p. 853, doi. 10.1111/bjh.16945
- By:
- Publication type:
- Article
Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. e83, doi. 10.1111/bjh.16874
- By:
- Publication type:
- Article
Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 6, p. 816, doi. 10.1111/bjh.15459
- By:
- Publication type:
- Article
Telomere length is a critical determinant for survival in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 1, p. 94, doi. 10.1111/bjh.14643
- By:
- Publication type:
- Article
Evolving concepts in tumour lysis syndrome management - response to Ayed et al.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 3, p. 486, doi. 10.1111/bjh.13616
- By:
- Publication type:
- Article
Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 661, doi. 10.1111/bjh.13403
- By:
- Publication type:
- Article
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 109, doi. 10.1111/bjh.12861
- By:
- Publication type:
- Article
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
- Published in:
- Nature Genetics, 2014, v. 46, n. 1, p. 56, doi. 10.1038/ng.2843
- By:
- Publication type:
- Article
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.
- Published in:
- Nature Genetics, 2013, v. 45, n. 10, p. 1221, doi. 10.1038/ng.2733
- By:
- Publication type:
- Article
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
- Published in:
- Nature Genetics, 2013, v. 45, n. 5, p. 522, doi. 10.1038/ng.2583
- By:
- Publication type:
- Article
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.
- Published in:
- Nature Genetics, 2012, v. 44, n. 1, p. 58, doi. 10.1038/ng.993
- By:
- Publication type:
- Article
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.
- Published in:
- Nature Genetics, 2008, v. 40, n. 10, p. 1204, doi. 10.1038/ng.219
- By:
- Publication type:
- Article
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
- Published in:
- Scientific Reports, 2017, p. 41071, doi. 10.1038/srep41071
- By:
- Publication type:
- Article
DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.
- Published in:
- Carcinogenesis, 2004, v. 25, n. 10, p. 1795, doi. 10.1093/carcin/bgh187
- By:
- Publication type:
- Article
Donor monocyte-derived macrophages promote human acute graft-versus-host disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
- Published in:
- Rheumatology, 2011, v. 50, n. 4, p. 810, doi. 10.1093/rheumatology/keq429
- By:
- Publication type:
- Article
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
- Published in:
- Nature Communications, 2016, v. 7, n. 1, p. 10290, doi. 10.1038/ncomms10290
- By:
- Publication type:
- Article
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.
- Published in:
- Nature Communications, 2015, v. 6, n. 4, p. 6997, doi. 10.1038/ncomms7997
- By:
- Publication type:
- Article
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e279, doi. 10.1016/j.clml.2021.10.008
- By:
- Publication type:
- Article
Active multiple myeloma suppresses and typically eliminates coexisting MGUS.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
- Published in:
- Human Genomics, 2019, v. 13, n. 1, p. N.PAG, doi. 10.1186/s40246-019-0231-5
- By:
- Publication type:
- Article
Primary treatment of low-grade non-Hodgkin's lymphoma using an all oral anthracycline-containing regimen, chlorambucil, idarubicin, dexamethasone (CID)--a phase II study.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00795-w
- By:
- Publication type:
- Article
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00795-w
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 2, p. 91, doi. 10.1002/gcc.22222
- By:
- Publication type:
- Article
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 10, p. 765, doi. 10.1002/gcc.20899
- By:
- Publication type:
- Article
Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma.
- Published in:
- Scientific Reports, 2015, p. 12473, doi. 10.1038/srep12473
- By:
- Publication type:
- Article
Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 2, p. 291, doi. 10.1111/bjh.12218
- By:
- Publication type:
- Article
Haematopoietic stem cell transplantation ( HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation ( BSBMT) data registry 1997-2009.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 6, p. 742, doi. 10.1111/j.1365-2141.2012.09122.x
- By:
- Publication type:
- Article
Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 1, p. 73, doi. 10.1111/j.1365-2141.2009.07614.x
- By:
- Publication type:
- Article
Polymorphisms of interleukin-1α constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 5, p. 778, doi. 10.1046/j.1365-2141.2003.04510.x
- By:
- Publication type:
- Article
Human herpesvirus 6 encephalitis following flag chemotherapy.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 1, p. 166, doi. 10.1046/j.1365-2141.2003.04395_6.x
- By:
- Publication type:
- Article
Relapse of acute lymphoblastic leukaemia 14 years after presentation: use of molecular techniques to confirm true re-emergence.
- Published in:
- British Journal of Haematology, 1994, v. 87, n. 2, p. 437, doi. 10.1111/j.1365-2141.1994.tb04942.x
- By:
- Publication type:
- Article